MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 89 filers reported holding MELINTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $137,000 | -81.5% | 171,748 | -8.3% | 0.00% | – |
| Q3 2018 | $740,000 | -33.6% | 187,212 | +6.8% | 0.00% | -100.0% |
| Q2 2018 | $1,114,000 | +101.4% | 175,356 | +134.8% | 0.00% | – |
| Q1 2018 | $553,000 | -26.6% | 74,668 | +56.8% | 0.00% | -100.0% |
| Q4 2017 | $753,000 | – | 47,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISTHMUS PARTNERS, LLC | 84,072 | $7,657,000 | 1.86% |
| Sterling Investment Advisors, Ltd. | 19 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |